Journal of Pediatric Surgery
Volume 45, Issue 3 , Pages 483-489 , March 2010

Activated protein C reduces intestinal injury in an experimental model of necrotizing enterocolitis

Received 5 September 2008 ,Revised 1 July 2009 ,Accepted 9 July 2009.

References 

  1. Esmon CT, Fukudome K. Cellular regulation of the protein C pathway. Semin Cell Biol. 1995;6:259–268
  2. Taylor FB, Peer GT, Lockhart MS, et al. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood. 2001;97:1685–1688
  3. Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V. Biochim Biophys Acta. 1979;571:333–342
  4. Griffin JH, Zlokovic B, Fernandez JA. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin Hematol. 2002;39:197–205
  5. Hirose K, Okajima K, Taoka Y, et al. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg. 2000;232:272–280
  6. Mizutani A, Okajima K, Uchiba M, et al. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood. 2000;95:3781–3787
  7. Schoots IG, Levi M, van Vliet AK, et al. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats. Crit Care Med. 2004;32:1375–1383
  8. Shibata M, Kumar SR, Amar A, et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation. 2001;103:1799–1805
  9. Dillon JP, Laing AJ, Cahill RA, et al. Activated protein C attenuates acute ischaemia reperfusion injury in skeletal muscle. J Orthop Res. 2005;23:1454–1459
  10. Levi M, Choi G, Schoots I, et al. Beyond sepsis: activated protein C and ischemia-reperfusion injury. Crit Care Med. 2004;32:309–312
  11. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368:1271–1283
  12. Gribar SC, Anand RJ, Sodhi CP, et al. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol. 2008;83:493–498
  13. Engum SA, Grosfeld JL. Necrotizing enterocolitis. Curr Opin Pediatr. 1998;10:123–130
  14. Puiman P, Stoll B. Animal models to study neonatal nutrition in humans. Curr Opin Clin Nutr Metab Care. 2008;11:601–606
  15. Holman RC, Stoll BJ, Clarke MJ, et al. The epidemiology of necrotizing enterocolitis mortality in the United States. Am J Public Health. 1997;87:2026–2031
  16. Stechmiller JK, Treloar D, Allen N. Gut dysfunction in critically ill patients: a review of the literature. Am J Crit Care. 1997;6:204–209
  17. Gollin G, Zieg PM, Cohn SM. Intestinal mucosal injury in critically ill surgical patients: preliminary observations. Am Surg. 1999;65:19–21
  18. Yesilirmak DC, Kumral A, Tugyan K, et al. Effects of activated protein C on neonatal hypoxic ischemic brain injury. Brain Res. 2008;1210:56–62
  19. Ozer EA, Kumral A, Ozer E, et al. Effect of retinoic acid on oxygen-induced lung in the newborn rat. Pediatr Pulmonol. 2005;39:35–40
  20. Musemeche CA, Baker JL, Feddersen RM. A model of intestinal ischemia in the neonatal rat utilizing superior mesenteric artery occlusion and intraluminal platelet-activating factor. J Surg Res. 1995;58:724–727
  21. Kumral A, Baskın B, Duman N, et al. Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation. Biol Neonate. 2003;84:325–329
  22. Heijmans C, Wesseldijk F, Munnikes R, et al. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm. 2006;1:1–8
  23. Furukawa M, Lee EL, Johnston JM. Platelet activating factor-induced ischemic bowel necrosis. The effect of platelet-activating factor acetylhydrolase. Pediatr Res. 1993;34:237–241
  24. Caplan MS, Sun XM, Hsueh W, et al. Role of platelet-activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr. 1990;116:960–964
  25. Wong SS, Sun NN, Hyde JD, et al. Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1 beta in rats. Lung. 2004;182:319–330
  26. Chen CM, Hou CC, Cheng KC, et al. Activated protein C therapy in a rat heat stroke model. Crit Care Med. 2006;34:1960–1966
  27. Contreras JL, Eckstein C, Smyth CA, et al. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes. 2004;53:2804–2814
  28. Holub M, Helcl M, Beran O, et al. Kinetics of immune parameters in a patient with sepsis caused by Streptococcus pyogenes treated with activated protein C. Scand J Infect Dis. 2004;36:485–488
  29. Yuksel M, Okajima K, Uchiba M, et al. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost. 2002;88:267–273
  30. Franscini N, Bachli EB, Blau N, et al. Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation. 2004;110:2903–2909
  31. Joyce DE, Grinnell BW. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factorkappaB. Crit Care Med. 2002;30:288–293
  32. Whittle BJ, Boughton-Smith NK, Moncada S. Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide, in the gastric mucosa. Ann NY Acad Sci. 1992;664:126–129
  33. Chokshi NK, Guner YS, Hunter CJ, et al. The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin Perinatol. 2008;32:92–99
  34. Tepperman BL, Brown JF, Whittle BJ. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol. 1993;265:214–218
  35. Ford H, Watkins S, Reblock K, et al. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg. 1997;32:275–282
  36. Guo H, Liu D, Gelbard H, Cheng T, et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 2004;41:563–572
  37. Joyce DE, Gelbert L, Ciaccia A, et al. Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem. 2001;276:11199–11203

PII: S0022-3468(09)00590-9

doi: 10.1016/j.jpedsurg.2009.07.077

Journal of Pediatric Surgery
Volume 45, Issue 3 , Pages 483-489 , March 2010

Article Tools

* Image Usage & Resolution